Which Antibiotics Cause Tendon Rupture?

Fluoroquinolones are the only class of antibiotics with a well-documented link to tendon rupture. Drugs in this group, including ciprofloxacin (Cipro), levofloxacin (Levaquin), and moxifloxacin (Avelox), carry a boxed warning from the U.S. Food and Drug Administration specifically about this risk. The overall incidence is low, estimated at roughly 0.1 to 0.4 percent for tendon problems in general and far less for actual rupture, but certain people face dramatically higher odds depending on age, other medications, and underlying health conditions.

Why Fluoroquinolones Damage Tendons

Tendons are built mostly from type I collagen, a tough protein that your body constantly maintains through a cycle of small-scale breakdown and rebuilding. Fluoroquinolones appear to throw that cycle off in several ways at once. Laboratory studies on human tendon cells show that ciprofloxacin ramps up production of an enzyme called MMP-2, which chews through type I collagen. In those experiments, the amount of intact collagen dropped measurably after ciprofloxacin treatment, while the enzymes that normally keep collagen breakdown in check stayed the same, meaning there was more destruction without a matching increase in protection.¹

Separate cell-culture work found that fluoroquinolones also trigger increases in other matrix-degrading enzymes and in markers of programmed cell death (apoptosis), meaning the drugs are not just weakening the collagen scaffold but actively killing the cells responsible for maintaining it.² Beyond the cellular level, fluoroquinolones also reduce the overall synthesis of collagen and proteoglycans, the molecules that give tendons their resilience and elasticity, and interfere with the remodeling process that is especially important after an injury.³

Magnesium appears to play a role in this process. In animal studies, supplementing with magnesium and vitamin E reduced quinolone-induced cartilage damage substantially. Rats on a magnesium-enriched diet had up to an 82 percent reduction in joint cartilage lesions compared with those on a normal diet, supporting the idea that disruption of magnesium-dependent pathways is part of how the drugs cause tissue damage.⁴ This has not been translated into a proven preventive strategy in humans, but it gives researchers a window into what is going wrong at the biochemical level.

Which Specific Fluoroquinolones Are Worst

The drugs most commonly reported in tendon rupture cases are ciprofloxacin, levofloxacin, and norfloxacin. As a class, current fluoroquinolone exposure roughly triples the risk of Achilles tendon rupture compared to nonuse.⁵ But the risk is not evenly distributed across individual drugs, and the evidence here gets surprisingly muddy.

A large retrospective study of over a million U.S. Medicare beneficiaries found that levofloxacin was the only fluoroquinolone with a clearly elevated risk, roughly doubling the odds of Achilles tendon rupture and raising rotator cuff rupture risk by about 16 percent within the first 30 days of use. Ciprofloxacin, despite being the most-prescribed fluoroquinolone and the one with the most lab evidence of collagen damage, showed no statistically significant increase in tendon rupture in that study. Neither did moxifloxacin.⁶

That result surprised many clinicians, and it does not mean ciprofloxacin is safe for tendons. Older case-control data consistently links ciprofloxacin to tendon injury, and the cell-culture evidence of collagen degradation is robust. The discrepancy may partly reflect differences in prescribing patterns, dosing, and the populations studied. But it does suggest that levofloxacin may deserve extra caution, and that the common assumption that all fluoroquinolones carry identical tendon risk is an oversimplification.

How Quickly Problems Can Appear

Tendon symptoms do not follow a predictable schedule. A review of published cases found the median time from starting a fluoroquinolone to the onset of tendon injury was about eight days. But symptoms have been reported as early as two hours after the very first dose and as late as six months after the last dose.⁷ That wide window matters for a practical reason: if you develop unexplained tendon pain weeks after finishing an antibiotic course, you and your doctor might not connect the two events. The association between fluoroquinolone exposure and tendon rupture persists for about 60 days after the last dose, based on population-level data.⁵

An earlier Dutch study found a similar pattern with a dose-response gradient: the odds ratio for Achilles tendon rupture was highest during current use, dropped during the period shortly after stopping, and faded to non-significant months later.⁸ The practical takeaway is that risk does not end the day you swallow the last pill. If you develop new Achilles or shoulder pain within a couple of months of a fluoroquinolone course, mention the antibiotic to your doctor.

Who Faces the Highest Risk

Several factors dramatically amplify the odds, and the biggest one is simultaneous use of oral corticosteroids like prednisone. In one population-based study, the combined use of a fluoroquinolone and a corticosteroid pushed the risk of Achilles tendon rupture to roughly 19 times that of someone taking neither drug.⁵ A separate analysis confirmed this interaction, finding that concomitant corticosteroid use raised the odds of any tendon rupture more than sixfold.⁹

Age matters almost as much. Patients over 60 face roughly two and a half times the risk of tendon rupture from fluoroquinolones compared with younger adults, based on the same analysis.⁹ Kidney problems are another major risk factor. In heart transplant recipients, who often take both corticosteroids and immunosuppressants, renal dysfunction was an independent predictor of quinolone-related tendon problems.¹⁰ Organ transplant recipients in general are a high-risk group because they tend to check multiple boxes at once: chronic corticosteroid use, reduced kidney function, and frequent antibiotic prescriptions.

The risk also appears to be higher in women than in men. One case-control study found an odds ratio of about 2.3 for women versus 1.6 overall.⁹ Physical activity level can add further strain. Strenuous exercise during or shortly after a fluoroquinolone course puts extra load on tendons that may already be structurally compromised, though quantifying that risk precisely from observational data is difficult.

Which Tendons Are Affected

The Achilles tendon gets most of the attention because it accounts for the vast majority of fluoroquinolone-associated ruptures. But it is not the only tendon at risk. Case reports and reviews describe involvement of the rotator cuff, the biceps tendon, the quadriceps and patellar tendons in the knee, and wrist extensor tendons.¹¹ A bilateral pattern, where the same tendon ruptures on both sides of the body, has been documented repeatedly. One published case involved both patellar tendons rupturing in the same patient, a pattern that is rare enough in the general population to raise immediate suspicion of a drug-related cause.

The Medicare study mentioned earlier is one of the few large datasets that examined non-Achilles tendons. It found that levofloxacin raised the risk of rotator cuff rupture as well, by about 16 percent within 30 days of use.⁶ Given that the rotator cuff is the most commonly torn tendon in the body to begin with, even a modest percentage increase in risk translates to a meaningful number of additional injuries in an older population.

Fluoroquinolones After Tendon Surgery

One question that does not get enough attention is what happens when someone who has recently had tendon surgery is prescribed a fluoroquinolone, say for a post-operative infection. A matched cohort study looked at over 124,000 patients who had primary tendon repair and found that those who received a fluoroquinolone prescription within 90 days of surgery had significantly higher rates of revision surgery. Patients given fluoroquinolones after Achilles repair were about twice as likely to need a reoperation compared with matched controls. The same pattern held for rotator cuff repairs and distal biceps repairs.¹²

This makes biological sense given what we know about how fluoroquinolones interfere with collagen remodeling. A healing tendon is in the middle of exactly the rebuilding process that these drugs disrupt. If you are recovering from tendon surgery and develop an infection, your surgeon and prescribing doctor should weigh alternative antibiotic classes carefully before defaulting to a fluoroquinolone.

The FDA Warning and How Prescribing Has Changed

The FDA first added a warning about tendon rupture to fluoroquinolone labels in 2008, then upgraded it to a boxed warning, the most prominent label change available. In 2016, the agency went further, recommending against fluoroquinolones as first-line treatment for uncomplicated urinary tract infections, acute sinusitis, and acute bronchitis in patients who have other options.¹³ The rationale was straightforward: for routine infections where safer alternatives exist, the risk-benefit balance does not favor a drug class with potentially disabling side effects.

That said, fluoroquinolones remain important antibiotics for certain serious infections, including complicated urinary tract and intra-abdominal infections, hospital-acquired pneumonia, and some bone infections. They are not going away. The shift is toward reserving them for situations where the benefit clearly outweighs the tendon risk, rather than prescribing them for a simple sinus infection because they are convenient.

Are Any Other Antibiotics Linked to Tendon Problems?

Fluoroquinolones are the only antibiotic class with a strong, consistent, and mechanistically understood association with tendon rupture. No penicillin, cephalosporin, macrolide (like azithromycin), tetracycline, or sulfonamide has been linked to tendon rupture in the way fluoroquinolones have. The large Medicare study specifically compared fluoroquinolone users to users of other oral antibiotics and found no elevated tendon rupture risk with the non-fluoroquinolone drugs.⁶

Occasional case reports pop up linking other medications to tendon issues, but the numbers are tiny and the causal evidence thin. If your concern is specifically about antibiotic-related tendon damage, fluoroquinolones are the class to watch.

What to Do If You Develop Tendon Pain on a Fluoroquinolone

The standard advice from prescribing guidelines is blunt: if you develop tendon pain, swelling, or inflammation while taking a fluoroquinolone, stop the drug and contact your doctor. This applies even if you are only a day or two into your prescription. Continuing to load a weakened tendon with exercise or daily activity while the drug is still on board raises the chance of a full rupture. Rest and immobilization in the acute phase are the immediate first steps.

In terms of recovery, a case series examining the largest published group of fluoroquinolone-associated Achilles ruptures found that functional rehabilitation produced meaningful improvements in outcomes over 12 months, suggesting that these injuries can be managed successfully with structured, non-surgical treatment programs in many cases.¹⁴ That is encouraging, though recovery timelines can be long, and some patients do require surgical repair, particularly when the rupture is complete or when the tendon tissue quality is very poor.

Fluoroquinolone Effects in Veterinary Medicine

The tendon-damaging effects of fluoroquinolones are not unique to humans. Enrofloxacin, a veterinary fluoroquinolone, inhibits the growth of tendon cells and cartilage cells in dogs at concentrations that climb toward the higher end of what is used clinically. Lab experiments showed that canine tendon cells treated with enrofloxacin exhibited DNA fragmentation and apoptosis in a dose- and time-dependent pattern, mirroring the mechanism seen in human tendon cells.¹⁵ This cross-species consistency strengthens the case that the tendon toxicity is an inherent property of the fluoroquinolone chemical structure, not something peculiar to human physiology. Veterinarians face the same trade-off: enrofloxacin is an effective antibiotic for certain infections in dogs and cats, but the risk to connective tissue is real, especially in young growing animals where the damage can affect joint cartilage as well as tendons.